Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma

BACKGROUND: Adult T-cell leukemia lymphoma (ATLL) is a chemotherapy-resistant malignancy with a median survival of less than one year that will afflict between one hundred thousand and one million individuals worldwide who are currently infected with human T-cell leukemia virus type 1. Recurrent som...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Retrovirology
Hlavní autoři: Rauch, Daniel A., Olson, Sydney L., Harding, John C., Sundaramoorthi, Hemalatha, Kim, Youngsoo, Zhou, Tianyuan, MacLeod, A. Robert, Challen, Grant, Ratner, Lee
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7456374/
https://ncbi.nlm.nih.gov/pubmed/32859220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12977-020-00535-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky